Log in to save to my catalogue

Somatic cancer mutations in the MLL 1 histone methyltransferase modulate its enzymatic activity and...

Somatic cancer mutations in the MLL 1 histone methyltransferase modulate its enzymatic activity and...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2290191860

Somatic cancer mutations in the MLL 1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR 5/ RBBP 5/ ASH 2L complex

About this item

Full title

Somatic cancer mutations in the MLL 1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR 5/ RBBP 5/ ASH 2L complex

Publisher

Hoboken: John Wiley & Sons, Inc

Journal title

Molecular oncology, 2017-04, Vol.11 (4), p.373-387

Language

English

Formats

Publication information

Publisher

Hoboken: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Somatic missense mutations in the mixed lineage leukemia 1 (
MLL
1) histone H3K4 methyltransferase are often observed in cancers.
MLL
1 forms a complex with
WDR
5,
RBBP
5, and
ASH
2L (
WRA
) which stimulates its activity. The
MM
‐102 compound prevents the interaction between
MLL
1 and
WDR
5 and...

Alternative Titles

Full title

Somatic cancer mutations in the MLL 1 histone methyltransferase modulate its enzymatic activity and dependence on the WDR 5/ RBBP 5/ ASH 2L complex

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2290191860

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2290191860

Other Identifiers

ISSN

1574-7891

E-ISSN

1878-0261

DOI

10.1002/1878-0261.12041

How to access this item